PRECISION BIOSCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PRECISION BIOSCIENCES INC (DTIL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 85.03K shares, a 315.96% increase from fiscal 2023.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 20.44K shares, a 90.86% decline from fiscal 2022.
- PRECISION BIOSCIENCES INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 223.67K shares, a 92.10% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-06 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-05 | ||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-12 | 0.00 shares 10-K · filed 2026-03-12 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 0.00 shares 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-07 | ||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 66.52K shares derived: sum of 2 quarters · filed 2026-03-12 | 85.03K shares 10-K · filed 2026-03-12 | ||
| 2024-09-30 | 66.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 85.03K shares 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | 18.51K shares 10-Q · filed 2024-08-01 | ||||
| 2023-12-31 | -433.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -433.04K shares derived: sum of 2 quarters · filed 2025-03-26 | -138.65K shares derived: sum of 3 quarters · filed 2025-03-26 | 20.44K shares 10-K · filed 2025-03-26 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 294.38K shares derived: sum of 2 quarters · filed 2023-11-07 | 453.48K shares 10-Q · filed 2023-11-07 | -5.51M shares derived: sum of 4 quarters · filed 2024-03-27 | |
| 2023-06-30 | 294.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 453.48K shares 10-Q · filed 2023-08-04 | -5.51M shares derived: sum of 3 quarters · filed 2024-03-27 | -4.93M shares derived: sum of 4 quarters · filed 2024-03-27 | |
| 2023-03-31 | 159.10K shares 10-Q · filed 2023-05-09 | -5.81M shares derived: sum of 2 quarters · filed 2024-03-27 | -5.23M shares derived: sum of 3 quarters · filed 2024-03-27 | -2.56M shares derived: sum of 4 quarters · filed 2024-03-27 | |
| 2022-12-31 | -5.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -5.38M shares derived: sum of 2 quarters · filed 2024-03-27 | -2.71M shares derived: sum of 3 quarters · filed 2024-03-27 | 223.67K shares 10-K · filed 2024-03-27 | 6.71M shares 10-K · filed 2023-03-09 |
| 2022-09-30 | 583.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 3.25M shares derived: sum of 2 quarters · filed 2022-11-08 | 6.19M shares 10-Q · filed 2022-11-08 | 7.18M shares derived: sum of 4 quarters · filed 2023-03-09 | |
| 2022-06-30 | 2.67M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 5.61M shares 10-Q · filed 2022-08-08 | 6.59M shares derived: sum of 3 quarters · filed 2023-03-09 | 6.61M shares derived: sum of 4 quarters · filed 2023-03-09 | |
| 2022-03-31 | 2.94M shares 10-Q · filed 2022-05-09 | 3.92M shares derived: sum of 2 quarters · filed 2023-03-09 | 3.94M shares derived: sum of 3 quarters · filed 2023-03-09 | 5.66M shares derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-12-31 | 985.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 1.01M shares derived: sum of 2 quarters · filed 2023-03-09 | 2.72M shares derived: sum of 3 quarters · filed 2023-03-09 | 2.83M shares 10-K · filed 2023-03-09 | |
| 2021-09-30 | 20.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 1.74M shares derived: sum of 2 quarters · filed 2021-11-10 | 1.85M shares 10-Q · filed 2021-11-10 | 2.35M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-06-30 | 1.72M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.82M shares 10-Q · filed 2021-08-12 | 2.33M shares derived: sum of 3 quarters · filed 2022-03-15 | 3.26M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-03-31 | 106.19K shares 10-Q · filed 2021-05-13 | 611.58K shares derived: sum of 2 quarters · filed 2022-03-15 | 1.54M shares derived: sum of 3 quarters · filed 2022-03-15 | 3.70M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-12-31 | 505.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 1.44M shares derived: sum of 2 quarters · filed 2022-03-15 | 3.60M shares derived: sum of 3 quarters · filed 2022-03-15 | 4.01M shares 10-K · filed 2022-03-15 | |
| 2020-09-30 | 929.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 3.09M shares derived: sum of 2 quarters · filed 2020-11-10 | 3.51M shares 10-Q · filed 2020-11-10 | 4.04M shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2020-06-30 | 2.16M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 2.58M shares 10-Q · filed 2020-08-13 | 3.11M shares derived: sum of 3 quarters · filed 2021-03-18 | 4.23M shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2020-03-31 | 414.86K shares 10-Q · filed 2020-05-15 | 946.76K shares derived: sum of 2 quarters · filed 2021-03-18 | 2.06M shares derived: sum of 3 quarters · filed 2021-03-18 | 2.51M shares derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-12-31 | 531.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 1.65M shares derived: sum of 2 quarters · filed 2021-03-18 | 2.10M shares derived: sum of 3 quarters · filed 2021-03-18 | 2.65M shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 1.12M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 1.56M shares derived: sum of 2 quarters · filed 2019-11-12 | 2.12M shares 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | 447.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 998.18K shares 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | 550.42K shares 10-Q · filed 2019-04-29 | ||||
| 2018-12-31 | 3.16M shares 10-K · filed 2020-03-10 | ||||
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |